There was a numerical trend for higher proportions of patients with eosinophil counts of ≥300 cells/μL with a history of 1 (41.0%) or ≥2 (39.4%) exacerbations compared with no exacerbations (25.0%).
← all excerpts
Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population.
1
—
—